Wall Street's M&A Chatter From December 6: DaVita Medical Group, Cleantech-Brighten Holdings, Walgreens-GuoDa

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday Dec. 6, 2017.

DaVita Medical Group Acquired by United Health Unit for $4.9B in Cash

The Deal

UnitedHealth Group Inc UNH unit Optum, and DaVita Medical Group, a subsidiary of DaVita Inc DVA, announced that Optum will acquire DaVita Medical Group for approximately $4.9 billion in cash. The transaction is expected to close in 2018, subject to regulatory approval.

DaVita closed Wednesday at $69.20, up $8.57.

Cleantech to Acquire 51% of Brighten Holdings

The Deal

Cleantech Solutions International, Inc. CLNT announced that its wholly-owned subsidiary, EC Assets Management Limited has entered into a conditional share swap agreement with Ever-Long Holdings Limited and certain officers and directors, to acquire a 51% interest in the issued share capital of Brighten Holdings in exchange for 19.5 percent of the issued and outstanding shares of Cleantech, and a 5-year interest-free promissory note with a principal amount of $13,762,125 to Brighten. The conditional agreement is subject to entry into a definitive agreement.

Cleantech Solutions closed at $5.65, up $0.34.

Walgreens Boots Alliance Acquires 40% of Chinese Pharmacy Chain GuoDa for $416M

The Deal

Walgreens Boots Alliance Inc WBA reached an agreement with China National Accord Medicines Corporation Ltd. to become an investor in its subsidiary Sinopharm Holding Guoda Drugstores Co., Ltd. Walgreens will acquire a 40 percent minority stake in GuoDa through a capital increase worth approximately $416 million.

The transaction is subject to regulatory review and approval.

Walgreens closed at $71.05, up 87 cents.